Trials / Completed
CompletedNCT02277574
Assess Safety, Tolerability, Pharmacokinetics and Clinical Activity of AMP-110 in Subjects With Rheumatoid Arthritis
A Randomized, Multi-Dose, Placebo-Controlled, Study of the Safety, Tolerability, Pharmacokinetics and Clinical Activity of AMP-110 in Subjects With Rheumatoid Arthritis
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 29 (actual)
- Sponsor
- MedImmune LLC · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This is a Phase 1b, randomized, multi-dose, placebo-controlled, dose-escalation, multi-center study of AMP-110 in adult subjects with rheumatoid arthritis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | AMP-110 | 2, 5, or 10 mg/kg |
| OTHER | Placebo | Placebo |
Timeline
- Start date
- 2014-06-01
- Primary completion
- 2015-01-01
- Completion
- 2015-07-01
- First posted
- 2014-10-29
- Last updated
- 2016-11-21
Locations
7 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02277574. Inclusion in this directory is not an endorsement.